Reviews Protonix


No reviews yet.

Protonix Drug Description
PROTONIX
(pantoprazole sodium) Delayed-Release Tablets
PROTONIX
(pantoprazole sodium) for Delayed-Release Oral Suspension
DRUG DESCRIPTION



What are the possible side effects of pantoprazole (Protonix)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Less serious side effects are more likely to occur, such as:

nausea, vomiting;
gas, stomach pain;
diarrhea; or
headache.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at...
Read All Potential Side Effects for Protonix »




The active ingredient in PROTONIX (pantoprazole sodium) For Delayed-Release
Oral Suspension and PROTONIX (pantoprazole sodium) Delayed-Release Tablets is
a substituted benzimidazole, sodium 5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]
sulfinyl]1H-benzimidazole sesquihydrate, a compound that inhibits gastric acid
secretion. Its empirical formula is C16H14F2N3NaO4S
x 1.5 H2O, with a molecular weight of 432.4. The structural formula
is:








Pantoprazole sodium sesquihydrate is a white to off-white crystalline powder
and is racemic. Pantoprazole has weakly basic and acidic properties. Pantoprazole
sodium sesquihydrate is freely soluble in water, very slightly soluble in phosphate
buffer at pH 7.4, and practically insoluble in n-hexane.
The stability of the compound in aqueous solution is pH-dependent. The rate
of degradation increases with decreasing pH. At ambient temperature, the degradation
half-life is approximately 2.8 hours at pH 5 and approximately 220 hours at
pH 7.8.
PROTONIX (pantoprazole sodium) is supplied as a for delayed-release oral suspension,
available in one strength (40 mg), and as a delayed-release tablet, available
in two strengths (20 mg and 40 mg).
Each PROTONIX (pantoprazole sodium) Delayed-Release Tablet contains 45.1 mg
or 22.56 mg of pantoprazole sodium sesquihydrate (equivalent to 40 mg or 20
mg pantoprazole, respectively) with the following inactive ingredients: calcium
stearate, crospovidone, hypromellose, iron oxide, mannitol, methacrylic acid
copolymer, polysorbate 80, povidone, propylene glycol, sodium carbonate, sodium
lauryl sulfate, titanium dioxide, and triethyl citrate. PROTONIX Delayed-Release
Tablets (40 mg and 20 mg) complies with USP dissolution test 2.
PROTONIX (pantoprazole sodium) For Delayed-Release Oral Suspension, 40 mg,
contains the active ingredient pantoprazole sodium sesquihydrate in the form
of enteric-coated granules in unit dose packets. Each unit dose packet contains
enteric-coated granules containing 45.1 mg pantoprazole sodium sesquihydrate
(equivalent to 40 mg of pantoprazole) with the following inactive ingredients:
crospovidone, hypromellose, methacrylic acid copolymer, microcrystalline cellulose,
polysorbate 80, povidone, sodium carbonate, sodium lauryl sulfate, talc, titanium
dioxide, triethyl citrate, and yellow ferric oxide.
Last reviewed on RxList: 12/7/2009




Protonix Drug Description
PROTONIX
(pantoprazole sodium) Delayed-Release Tablets
PROTONIX
(pantoprazole sodium) for Delayed-Release Oral Suspension
DRUG DESCRIPTION



What are the possible side effects of pantoprazole (Protonix)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Less serious side effects are more likely to occur, such as:

nausea, vomiting;
gas, stomach pain;
diarrhea; or
headache.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at...
Read All Potential Side Effects for Protonix »




The active ingredient in PROTONIX (pantoprazole sodium) For Delayed-Release
Oral Suspension and PROTONIX (pantoprazole sodium) Delayed-Release Tablets is
a substituted benzimidazole, sodium 5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]
sulfinyl]1H-benzimidazole sesquihydrate, a compound that inhibits gastric acid
secretion. Its empirical formula is C16H14F2N3NaO4S
x 1.5 H2O, with a molecular weight of 432.4. The structural formula
is:








Pantoprazole sodium sesquihydrate is a white to off-white crystalline powder
and is racemic. Pantoprazole has weakly basic and acidic properties. Pantoprazole
sodium sesquihydrate is freely soluble in water, very slightly soluble in phosphate
buffer at pH 7.4, and practically insoluble in n-hexane.
The stability of the compound in aqueous solution is pH-dependent. The rate
of degradation increases with decreasing pH. At ambient temperature, the degradation
half-life is approximately 2.8 hours at pH 5 and approximately 220 hours at
pH 7.8.
PROTONIX (pantoprazole sodium) is supplied as a for delayed-release oral suspension,
available in one strength (40 mg), and as a delayed-release tablet, available
in two strengths (20 mg and 40 mg).
Each PROTONIX (pantoprazole sodium) Delayed-Release Tablet contains 45.1 mg
or 22.56 mg of pantoprazole sodium sesquihydrate (equivalent to 40 mg or 20
mg pantoprazole, respectively) with the following inactive ingredients: calcium
stearate, crospovidone, hypromellose, iron oxide, mannitol, methacrylic acid
copolymer, polysorbate 80, povidone, propylene glycol, sodium carbonate, sodium
lauryl sulfate, titanium dioxide, and triethyl citrate. PROTONIX Delayed-Release
Tablets (40 mg and 20 mg) complies with USP dissolution test 2.
PROTONIX (pantoprazole sodium) For Delayed-Release Oral Suspension, 40 mg,
contains the active ingredient pantoprazole sodium sesquihydrate in the form
of enteric-coated granules in unit dose packets. Each unit dose packet contains
enteric-coated granules containing 45.1 mg pantoprazole sodium sesquihydrate
(equivalent to 40 mg of pantoprazole) with the following inactive ingredients:
crospovidone, hypromellose, methacrylic acid copolymer, microcrystalline cellulose,
polysorbate 80, povidone, sodium carbonate, sodium lauryl sulfate, talc, titanium
dioxide, triethyl citrate, and yellow ferric oxide.
Last reviewed on RxList: 12/7/2009




Protonix Drug Description
PROTONIX
(pantoprazole sodium) Delayed-Release Tablets
PROTONIX
(pantoprazole sodium) for Delayed-Release Oral Suspension
DRUG DESCRIPTION



What are the possible side effects of pantoprazole (Protonix)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Less serious side effects are more likely to occur, such as:

nausea, vomiting;
gas, stomach pain;
diarrhea; or
headache.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at...
Read All Potential Side Effects for Protonix »




The active ingredient in PROTONIX (pantoprazole sodium) For Delayed-Release
Oral Suspension and PROTONIX (pantoprazole sodium) Delayed-Release Tablets is
a substituted benzimidazole, sodium 5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]
sulfinyl]1H-benzimidazole sesquihydrate, a compound that inhibits gastric acid
secretion. Its empirical formula is C16H14F2N3NaO4S
x 1.5 H2O, with a molecular weight of 432.4. The structural formula
is:








Pantoprazole sodium sesquihydrate is a white to off-white crystalline powder
and is racemic. Pantoprazole has weakly basic and acidic properties. Pantoprazole
sodium sesquihydrate is freely soluble in water, very slightly soluble in phosphate
buffer at pH 7.4, and practically insoluble in n-hexane.
The stability of the compound in aqueous solution is pH-dependent. The rate
of degradation increases with decreasing pH. At ambient temperature, the degradation
half-life is approximately 2.8 hours at pH 5 and approximately 220 hours at
pH 7.8.
PROTONIX (pantoprazole sodium) is supplied as a for delayed-release oral suspension,
available in one strength (40 mg), and as a delayed-release tablet, available
in two strengths (20 mg and 40 mg).
Each PROTONIX (pantoprazole sodium) Delayed-Release Tablet contains 45.1 mg
or 22.56 mg of pantoprazole sodium sesquihydrate (equivalent to 40 mg or 20
mg pantoprazole, respectively) with the following inactive ingredients: calcium
stearate, crospovidone, hypromellose, iron oxide, mannitol, methacrylic acid
copolymer, polysorbate 80, povidone, propylene glycol, sodium carbonate, sodium
lauryl sulfate, titanium dioxide, and triethyl citrate. PROTONIX Delayed-Release
Tablets (40 mg and 20 mg) complies with USP dissolution test 2.
PROTONIX (pantoprazole sodium) For Delayed-Release Oral Suspension, 40 mg,
contains the active ingredient pantoprazole sodium sesquihydrate in the form
of enteric-coated granules in unit dose packets. Each unit dose packet contains
enteric-coated granules containing 45.1 mg pantoprazole sodium sesquihydrate
(equivalent to 40 mg of pantoprazole) with the following inactive ingredients:
crospovidone, hypromellose, methacrylic acid copolymer, microcrystalline cellulose,
polysorbate 80, povidone, sodium carbonate, sodium lauryl sulfate, talc, titanium
dioxide, triethyl citrate, and yellow ferric oxide.
Last reviewed on RxList: 12/7/2009




Protonix Drug Description
PROTONIX
(pantoprazole sodium) Delayed-Release Tablets
PROTONIX
(pantoprazole sodium) for Delayed-Release Oral Suspension
DRUG DESCRIPTION



What are the possible side effects of pantoprazole (Protonix)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Less serious side effects are more likely to occur, such as:

nausea, vomiting;
gas, stomach pain;
diarrhea; or
headache.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at...
Read All Potential Side Effects for Protonix »




The active ingredient in PROTONIX (pantoprazole sodium) For Delayed-Release
Oral Suspension and PROTONIX (pantoprazole sodium) Delayed-Release Tablets is
a substituted benzimidazole, sodium 5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]
sulfinyl]1H-benzimidazole sesquihydrate, a compound that inhibits gastric acid
secretion. Its empirical formula is C16H14F2N3NaO4S
x 1.5 H2O, with a molecular weight of 432.4. The structural formula
is:








Pantoprazole sodium sesquihydrate is a white to off-white crystalline powder
and is racemic. Pantoprazole has weakly basic and acidic properties. Pantoprazole
sodium sesquihydrate is freely soluble in water, very slightly soluble in phosphate
buffer at pH 7.4, and practically insoluble in n-hexane.
The stability of the compound in aqueous solution is pH-dependent. The rate
of degradation increases with decreasing pH. At ambient temperature, the degradation
half-life is approximately 2.8 hours at pH 5 and approximately 220 hours at
pH 7.8.
PROTONIX (pantoprazole sodium) is supplied as a for delayed-release oral suspension,
available in one strength (40 mg), and as a delayed-release tablet, available
in two strengths (20 mg and 40 mg).
Each PROTONIX (pantoprazole sodium) Delayed-Release Tablet contains 45.1 mg
or 22.56 mg of pantoprazole sodium sesquihydrate (equivalent to 40 mg or 20
mg pantoprazole, respectively) with the following inactive ingredients: calcium
stearate, crospovidone, hypromellose, iron oxide, mannitol, methacrylic acid
copolymer, polysorbate 80, povidone, propylene glycol, sodium carbonate, sodium
lauryl sulfate, titanium dioxide, and triethyl citrate. PROTONIX Delayed-Release
Tablets (40 mg and 20 mg) complies with USP dissolution test 2.
PROTONIX (pantoprazole sodium) For Delayed-Release Oral Suspension, 40 mg,
contains the active ingredient pantoprazole sodium sesquihydrate in the form
of enteric-coated granules in unit dose packets. Each unit dose packet contains
enteric-coated granules containing 45.1 mg pantoprazole sodium sesquihydrate
(equivalent to 40 mg of pantoprazole) with the following inactive ingredients:
crospovidone, hypromellose, methacrylic acid copolymer, microcrystalline cellulose,
polysorbate 80, povidone, sodium carbonate, sodium lauryl sulfate, talc, titanium
dioxide, triethyl citrate, and yellow ferric oxide.
Last reviewed on RxList: 12/7/2009




Protonix Drug Description
PROTONIX
(pantoprazole sodium) Delayed-Release Tablets
PROTONIX
(pantoprazole sodium) for Delayed-Release Oral Suspension
DRUG DESCRIPTION



What are the possible side effects of pantoprazole (Protonix)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Less serious side effects are more likely to occur, such as:

nausea, vomiting;
gas, stomach pain;
diarrhea; or
headache.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at...
Read All Potential Side Effects for Protonix »




The active ingredient in PROTONIX (pantoprazole sodium) For Delayed-Release
Oral Suspension and PROTONIX (pantoprazole sodium) Delayed-Release Tablets is
a substituted benzimidazole, sodium 5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]
sulfinyl]1H-benzimidazole sesquihydrate, a compound that inhibits gastric acid
secretion. Its empirical formula is C16H14F2N3NaO4S
x 1.5 H2O, with a molecular weight of 432.4. The structural formula
is:








Pantoprazole sodium sesquihydrate is a white to off-white crystalline powder
and is racemic. Pantoprazole has weakly basic and acidic properties. Pantoprazole
sodium sesquihydrate is freely soluble in water, very slightly soluble in phosphate
buffer at pH 7.4, and practically insoluble in n-hexane.
The stability of the compound in aqueous solution is pH-dependent. The rate
of degradation increases with decreasing pH. At ambient temperature, the degradation
half-life is approximately 2.8 hours at pH 5 and approximately 220 hours at
pH 7.8.
PROTONIX (pantoprazole sodium) is supplied as a for delayed-release oral suspension,
available in one strength (40 mg), and as a delayed-release tablet, available
in two strengths (20 mg and 40 mg).
Each PROTONIX (pantoprazole sodium) Delayed-Release Tablet contains 45.1 mg
or 22.56 mg of pantoprazole sodium sesquihydrate (equivalent to 40 mg or 20
mg pantoprazole, respectively) with the following inactive ingredients: calcium
stearate, crospovidone, hypromellose, iron oxide, mannitol, methacrylic acid
copolymer, polysorbate 80, povidone, propylene glycol, sodium carbonate, sodium
lauryl sulfate, titanium dioxide, and triethyl citrate. PROTONIX Delayed-Release
Tablets (40 mg and 20 mg) complies with USP dissolution test 2.
PROTONIX (pantoprazole sodium) For Delayed-Release Oral Suspension, 40 mg,
contains the active ingredient pantoprazole sodium sesquihydrate in the form
of enteric-coated granules in unit dose packets. Each unit dose packet contains
enteric-coated granules containing 45.1 mg pantoprazole sodium sesquihydrate
(equivalent to 40 mg of pantoprazole) with the following inactive ingredients:
crospovidone, hypromellose, methacrylic acid copolymer, microcrystalline cellulose,
polysorbate 80, povidone, sodium carbonate, sodium lauryl sulfate, talc, titanium
dioxide, triethyl citrate, and yellow ferric oxide.
Last reviewed on RxList: 12/7/2009





Other reviews about Protonix on wordpress

Buy Protonix Online Order Cheap Protonix Generic Purchase Discount Without Prescription
  by worlddnews
FOLLOW THIS LINK FOR ENTER TO TRUSTED & REPUTABLE ONLINE DRUGSTORE WHERE YOU CAN GET ALL QUALIFIED INFORMATION ABOUT Protonix ONLINE     There also this popular belief. Such episodes are […]


Protonix and Points
  by friendsonaweightlossjourney
So, I am just over the 200 mark so I am supposed to get 26 WW points per day. But, at 199 I go down to 24 so […]


Protonix
  by medsaccount
What is Protonix? Protonix is in a group of drugs called proton pump inhibitors. It decreases the amount of acid produced in the stomach. Protonix is used […]


Teva Gives Wyeth Heartburn
  by Dr Michael Factor
Teva Pharmaceutical Industries Ltd. has launched a generic version of Protonix, a heartburn pill owned by Wyeth in the U.S. market. So what's new? Well, in this instance, Teva has […]


ACIPHEX® (rabeprazole sodium) Delayed Release Tablets
  by kanlayanee
[caption id="" align="alignnone" width="192" caption="ACIPHEX"][/caption] RABEPRAZOLE (ACIPHEX™) prevents the production of acid in the stomach. It reduces symptoms and prevents injury to the esophagus or stomach in patients with […]


PROTONIX® (pantoprazole sodium) Delayed-Release Tablets PROTONIX® (pantoprazole sodium) For Delayed-Release Oral Suspension
  by kanlayanee
[caption id="" align="alignnone" width="288" caption=" PROTONIX 20 MG TABLET EC WYETH PHARM Approx. Price: $428.76 per 90Each"][/caption] Pantoprazole sodium, commonly referred to as […]


Don’t take Plavix with acid reducers
  by Health News
The Food and Drug Administration warns that acid-reflux drugs Prilosec and Nexium should not be taken with blood-thinner Plavix. Plavix’s label cautions against the use of the heartburn drugs, […]


Jury finds Protonix patent infringed by Teva
  by Dr Michael Factor
[gallery link="file" order="DESC"] A jury in the U.S. District Court for New Jersey has found in favour of Pfizer, ruling that the patent on its Protonix acid reflux drug is […]


WHISTLEBLOWER LAWSUIT FILED AGAINST WYETH
  by KIRBY JOHNSON, PC
The state of Utah has announced that it will join two lawsuits with 16 other states against drug manufacturing company Wyeth over the alleged concealment of discounted prices. […]


drug interaction clopidogrel/plavix and omeprazole/prilosec not clopidogrel and pantoprazole/protonix
  by drrutledge
drug interaction clopidogrel/plavix and omeprazole/prilosec not clopidogrel and pantoprazole/protonix The results suggest that a metabolic drug–drug interaction exists between clopidogrel and omeprazole but not between clopidogrel and pantoprazole. Omeprazole (Brand […]



Other reviews about Protonix on web:

Wyeth is now a part of Pfizer Inc. The merger of local Wyeth and Pfizer entities may be pending in various jurisdictions and is subject to completion of various local legal Wyeth Under Construction


Protonix (pantoprazole) is used to treat erosive esophagitis and other conditions involving excess stomach acid. Includes Protonix side effects, interactions and indications. Protonix (pantoprazole) Information from Drugs.com


Learn about the prescription medication Protonix (Pantoprazole), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling. Protonix (Pantoprazole) Drug Information: Uses, Side Effects, Drug ...


Pantoprazole (sold under various brand names including Protium and Protonix) is a proton pump inhibitor drug used for short-term treatment of erosion and ulceration of the ... Pantoprazole - Wikipedia, the free encyclopedia


Protonix information from Drugs.com. Protonix blocks the production of stomach acid. It is prescribed to heal a condition called erosive esophagitis (a severe inflammation of the ... Protonix patient advice including side effects


Find patient medical information for Protonix Oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings. Protonix Oral : Uses, Side Effects, Interactions, Pictures ...


Protonix side effects, dosage, and drug interactions. All accurate, up-to-date information is written for the consumer by healthcare professionals. Protonix Oral Uses and How to Use


Protonix is prescribed to treat damage to the erosive esophagitis and Zollinger-Ellison Syndrome. Learn about special precautions and side effects. Protonix - Proton Pump Inhibitor - Treatment for Acid Reflux


Protonix is a drug used to treat gastroesophageal reflux disease (GERD) and other conditions. This eMedTV article offers an overview of Protonix, including information about ... Protonix


Learn about Protonix from the publishers of the Physicians Desk Reference. Find prescription drug information resources including interactions, side effects, symptoms ... Protonix | Prescription Drug Information, Side Effects | PDRHealth





Featured Reviews

Reviews Haloperidol Injection

Haldol Drug Description HALDOL® (haloperidol) Injection (For Immediate Release) WARNING Increased Mortality in Elderly Patients with Dementia-Related Psychosis Elderly patients with dementia-related psychosis treated with...
Read More  |  Review This
Reviews Opana

Opana Drug Description OPANA® (oxymorphone hydrochloride) WARNING: OPANA contains oxymorphone, which is a morphine-like opioid agonist and a Schedule II controlled substance, with an abuse liability similar to other opioid...
Read More  |  Review This
Reviews Periostat

Periostat Drug Description PERIOSTAT® (doxycycline hyclate) 20 mg Tablets DRUG DESCRIPTION What are the possible side effects of doxycycline? Get emergency medical help if you have any of these signs of an allergic reaction:...
Read More  |  Review This
Reviews Lymerix

Lymerix Drug Description Lymerix™ Lyme Disease Vaccine (Recombinant OspA) DRUG DESCRIPTION LYMErix [Lyme Disease Vaccine (Recombinant OspA)] is a noninfectious recombinant vaccine developed and manufactured by Smith Kline Beecham Biologicals....
Read More  |  Review This
Reviews Neosporin Ophthalmic Ointment

Neosporin Ophthalmic Ointment Drug Description NEOSPORIN® Ophthalmic Ointment Sterile (neomycin and polymyxin B sulfates and bacitracin zinc) Ophthalmic Ointment, USP) DRUG DESCRIPTION NEOSPORIN Ophthalmic Ointment (neomycin and polymyxin...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....